The Trump administration’s cuts to university research grants will make America sicker and poorer in the long run.

Some think investing in stocks requires substantial start-up capital, but that's false. Even with a modest sum, like $40, ...

AMN Healthcare Services said Mark Foletta was named its new chairman of the board. He succeeds Douglas Wheat, who had served on the board since 1999.

CagriSema combines the GLP-1 receptor agonist (GLP-1RA) semaglutide, used in blockbuster weight-loss drug Wegovy, with dual ...

Truist lowered the firm’s price target on Viking Therapeutics (VKTX) to $95 from $120 and keeps a Buy rating on the shares. The company’s Q4 ...

Stephanie Diaz; Investor Relations Manager; Viking Therapeutics Inc. Brian Lian; President, Chief Executive Officer, Director; Viking Therapeutics Inc. Greg Zante; C ...

Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

In obesity, Lilly removed a dual amylin calcitonin receptor agonist (DACRA) from its phase 1 pipeline. Lilly got into DACRAs by partnering with KeyBioscience in 2017. At one time, the Big Pharma was ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...